Cliff Asness's JNJ Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 4.33 M shares of Johnson & Johnson (JNJ) worth $793.04 M, representing 0.51% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 1.79 M shares. Largest reduction occurred in Q4 2015, reducing 1 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +1.95 M | Add 0.00% | 1.95 M | $70.10 |
| Q2 2013 | +2.3 M | Add 0.00% | 2.3 M | $85.86 |
| Q3 2013 | +380,287 | Add 16.57% | 2.68 M | $86.69 |
| Q4 2013 | +371,000 | Add 13.87% | 3.05 M | $91.59 |
| Q1 2014 | +560,300 | Add 18.39% | 3.61 M | $98.23 |
| Q2 2014 | +38,100 | Add 1.06% | 3.64 M | $104.62 |
| Q3 2014 | -154,106 | Reduce 4.23% | 3.49 M | $106.59 |
| Q4 2014 | +971,484 | Add 27.83% | 4.46 M | $104.57 |
| Q1 2015 | +7,037 | Add 0.16% | 4.47 M | $100.60 |
| Q2 2015 | +85,850 | Add 1.92% | 4.56 M | $97.46 |
| Q3 2015 | -992,615 | Reduce 21.79% | 3.56 M | $93.35 |
| Q4 2015 | -1 M | Reduce 28.11% | 2.56 M | $102.72 |
| Q1 2016 | +865,734 | Add 33.81% | 3.43 M | $108.20 |
| Q2 2016 | +796,335 | Add 23.24% | 4.22 M | $121.30 |
| Q3 2016 | +1.45 M | Add 34.24% | 5.67 M | $118.13 |
| Q4 2016 | +585,337 | Add 10.33% | 6.25 M | $115.21 |
| Q1 2017 | -514,782 | Reduce 8.23% | 5.74 M | $124.55 |
| Q2 2017 | -825,096 | Reduce 14.38% | 4.91 M | $132.29 |
| Q3 2017 | +19,782 | Add 0.40% | 4.93 M | $130.01 |
| Q4 2017 | +469,417 | Add 9.51% | 5.4 M | $139.72 |
| Q1 2018 | +58,968 | Add 1.09% | 5.46 M | $128.15 |
| Q2 2018 | -330,303 | Reduce 6.05% | 5.13 M | $121.34 |
| Q3 2018 | +1.5 M | Add 29.18% | 6.63 M | $138.17 |
| Q4 2018 | +17,242 | Add 0.26% | 6.65 M | $129.05 |
| Q1 2019 | -283,722 | Reduce 4.27% | 6.36 M | $139.79 |
| Q2 2019 | +255,975 | Add 4.02% | 6.62 M | $139.28 |
| Q3 2019 | +43,577 | Add 0.66% | 6.66 M | $129.38 |
| Q4 2019 | +377,617 | Add 5.67% | 7.04 M | $144.94 |
| Q1 2020 | -998,264 | Reduce 14.18% | 6.04 M | $131.13 |
| Q2 2020 | -719,229 | Reduce 11.90% | 5.32 M | $138.18 |
| Q3 2020 | -524,478 | Reduce 9.85% | 4.8 M | $147.08 |
| Q4 2020 | -495,951 | Reduce 10.34% | 4.3 M | $156.15 |
| Q1 2021 | -200,399 | Reduce 4.66% | 4.1 M | $163.74 |
| Q2 2021 | -987,489 | Reduce 24.07% | 3.11 M | $163.97 |
| Q3 2021 | -68,907 | Reduce 2.21% | 3.05 M | $161.50 |
| Q4 2021 | -59,721 | Reduce 1.96% | 2.99 M | $171.07 |
| Q1 2022 | -6,054 | Reduce 0.20% | 2.98 M | $177.23 |
| Q2 2022 | -882,307 | Reduce 29.61% | 2.1 M | $176.31 |
| Q3 2022 | -100,513 | Reduce 4.79% | 2 M | $163.36 |
| Q4 2022 | -150,837 | Reduce 7.55% | 1.85 M | $176.65 |
| Q1 2023 | +144,264 | Add 7.81% | 1.99 M | $153.86 |
| Q2 2023 | -475,185 | Reduce 23.87% | 1.52 M | $164.56 |
| Q3 2023 | -9,385 | Reduce 0.62% | 1.51 M | $155.75 |
| Q4 2023 | +365,977 | Add 24.30% | 1.87 M | $156.42 |
| Q1 2024 | +545,805 | Add 29.16% | 2.42 M | $158.19 |
| Q2 2024 | +932,477 | Add 38.57% | 3.35 M | $146.01 |
| Q3 2024 | -191,329 | Reduce 5.71% | 3.16 M | $161.42 |
| Q4 2024 | +313,672 | Add 9.93% | 3.47 M | $144.01 |
| Q1 2025 | +1.79 M | Add 51.63% | 5.27 M | $165.84 |
| Q2 2025 | -470,221 | Reduce 8.93% | 4.8 M | $151.96 |
| Q3 2025 | -469,037 | Reduce 9.78% | 4.33 M | $183.30 |
Cliff Asness's Johnson & Johnson Investment FAQs
Cliff Asness first purchased Johnson & Johnson (JNJ) in Q4 2012, acquiring 1,951,850 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Johnson & Johnson (JNJ) for 52 quarters since Q4 2012. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 2,295,161 shares worth $197.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 4,326,452 shares of Johnson & Johnson (JNJ), valued at approximately $793.04 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.51% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Johnson & Johnson (JNJ) was 7,040,488 shares, as reported at the end of Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.